ArticleJournal of inflammation research2025
Identification of SIN3A as a Promising Epigenetic Target Against Allergic Rhinitis.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metabolic-Epigenetic Crosstalk in Takayasu Arteritis: The ANK2-MAVS-IL-8 Axis as a Novel Therapeutic Paradigm.International journal of molecular sciences · 2026Review
- Advances in clinical examination techniques for allergic rhinitis: a review from traditional testing to precision diagnosis.Frontiers in allergy · 2026Review
- HDAC8 impairs tight junctions in allergic rhinitis through Smad7 deacetylation.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The involvement of histone modifications in the development of other airway allergic diseases has been widely studied and followed, however, the role in allergic rhinitis(AR) has not been explored and discussed. Methods: We downloaded GSE50223 from Gene Expression Omnibus database, obtained histone modification related genes in FACER database, and identified key functional genes related to histone modification in AR by WGCNA and single cell sequencing analysis. Finally, we collected nasal mucosa tissues from AR patients and healthy individuals to verify the expression of the target gene. At the functional level, a co-culture system of house dust mite (HDM)-sensitized human nasal epithelial cells and naive CD4⁺ T cells was employed. Using gene knockdown and overexpression techniques, the role of SIN3A in the differentiation of Th17 and Treg cells was analyzed. Results: SIN3A was identified as a key functional gene related to histone modification with differential expression in AR, and single-cell data analysis showed that SIN3A might be involved in the immune infiltration difference by regulating Treg cells and thus. Upregulation of SIN3A was confirmed in nasal mucosal tissues of AR patients. Functional experiments demonstrated that SIN3A promotes the differentiation of naive T cells into Th17 cells and inhibits their differentiation into Treg cells, thereby disrupting the Th17/Treg balance. Conclusion: Histone modification-related gene SIN3A is differentially expressed in AR and healthy populations. SIN3A may play a significant role in the pathogenesis of AR by regulating the Th17/Treg immune balance. This study first revealed a novel epigenetic mechanism by which SIN3A mediates immune imbalance in allergic rhinitis (AR), providing a theoretical basis for the development of intervention strategies targeting SIN3A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.